The p53 tumour suppressor functions as a sensor of genotoxic stress and, once activated, induces cell growth arrest or apoptosis. The precise intranuclear localization of latent p53 protein in non-stressed cells is unknown. Such information is essential in order to understand how relatively few molecules of p53 can detect and respond to DNA damage. Here we present the ®rst detailed supramolecular localization of p53 in the nuclei of cells under normal conditions of growth. We show that soluble, non-bound p53 is released by permeabilization, leaving structurally bound p53 in both the nucleus and nucleolus. In situ biochemical studies reveal (i) that nuclear-bound p53 is tethered by RNA (directly or indirectly) and (ii) that a sub-population of nuclearbound p53 co-localizes with sites of RNA synthesis. Transcriptional co-localization appeared to be independent of p53 conformation but dependent upon its quaternary structure. In the nucleolus p53 was observed at sites of rRNA synthesis and also adjacent to such sites. In contrast, nucleolar hdm-2 (shown by others to complex p53 and 5S RNA) was excluded from sites of rRNA synthesis. Our discovery that p53 is physically linked with sites of transcription may explain how relatively few p53 protein molecules can monitor genetic stress and respond preferentially to damage of actively transcribed genes. Oncogene (2000) 19, 85 ± 96.
Introduction
The p53 tumour suppressor protein is well known to respond to DNA damage by inducing either G 1 arrest or apoptosis. Under normal conditions of cell growth, the p53 protein exists at very low levels and is inactive for many functions, including the transactivation of speci®c target genes. Nonetheless the protein is sensitive to genotoxic stress which activates p53 functions, thereby inducing a p53 response (reviewed in Ko and Prives, 1996; Levine, 1997) .
A variety of chemical and physical anti-tumour agents make use of DNA damage-mediated induction of p53 in order to eliminate tumour cells (see for example Weinstein et al., 1997) . These agents have various eects on DNA, including base modi®cation (UV), intercalation (adriamycin, actinomycin D), strand distortion (cis-Pt), double strand break (gradiation) . The sensitivity of p53 as a DNA damage sensor is remarkable and Huang et al. (1996) have shown that a single double strand break in DNA may be sucient to trigger a p53 response. However, the mechanism of p53 activation is poorly understood. Such information is important and may indicate new strategies for the development of anti-cancer agents with minimal side eects.
As a ®rst step towards understanding the cellular p53 response we have characterized the supramolecular distribution of p53 in the nucleus of cells maintained under normal growth conditions (i.e. latent, nonactivated p53). Three major sites were observed for latent p53: (i) soluble in the nucleoplasm, (ii) bound at nucleoplasmic structures and (iii) bound within the nucleolus. There is indirect evidence that latent p53 responds preferentially to damage of actively transcribed genes (Yamaizumi and Sugano, 1994 ; see Discussion) and we asked if the bound p53 is associated with sites of active transcription. To this end we used a combination of run-on transcription experiments and microinjection to label sites of RNA synthesis. Localization of p53 and sites of active transcription were characterized by confocal microscopy and image analysis. We demonstrate that subpopulations of both nucleoplasmic and nucleolar p53 co-localize with sites of RNA synthesis. The discovery that p53 is associated with transcription complexes might explain how relatively few p53 molecules can eciently monitor the genome for DNA damage. Furthermore, they provide a structural explanation for the preferential trigger of a p53 response by damage to actively transcribed genes.
Results

p53 in Hep G2 cells
The human Hep G2 cell line was chosen for study since these cells retain normal wild type p53 expression and can be activated in response to DNA damage (MuÈ ller et al., 1997) . Moreover the cell line appears stable and is free of any known viral agents which might aect p53 (Knowles et al., 1980) . The cells grow as monolayers and adhere well to poly-L-lysine-coated coverslips used for the microscopy and, importantly, they are amenable to cytoplasmic microinjection used in some of the experiments.
In non-stressed Hep G2 cells the p53 protein was undetectable by conventional indirect immuno¯uores-cence (data not shown). We therefore resorted to a biotin-streptavidin ampli®cation procedure to visualize p53, using the DO-1 anti-p53 monoclonal antibody, which recognizes an N-terminal epitope and shows no reactivity when tested in p53-null human cell lines (results not shown, see also Bonsing et al., 1997) . Antibodies against other regions of p53 show crossreactivity against other cellular proteins in p53-null cell lines (e.g. Saos-2 cells, results not shown; see also Bonsing et al., 1997 ; see list of antibodies tested in Materials and methods section). Therefore only noncross-reactive anti-N-terminus antibodies were used in the present work. DO-1 immuno¯uorescence reveals a punctate staining of p53 in the nucleus (Figure 1a,b) . This is more noticeable in a single confocal section (e.g. Figure 1a ).
As already described by Zerrahn et al. (1992) , nuclear p53 exists in bound and soluble forms. This is con®rmed in Hep G2 cells by immunoblotting which reveals a fraction of p53 bound within the nucleus after permeabilization and extraction of soluble proteins (Figure 2a ; lane 1: bound p53, lane 2: soluble p53). The bound fraction of p53 is also evident by immunouorescent staining of the permeabilized cells ( Figure  1c ). Hep G2 cells respond normally to DNA damage by increasing the p53 levels and we show that the bound and soluble forms of p53 are also present during a genotoxic response (Figure 2a , lanes 3 and 4, respectively).
P53 can bind to either of two nuclear structures that remain after cell permeabilization: chromatin and/or the nuclear matrix. The latter is a complex network of nuclear proteins and RNA (He et al., 1990; Pederson, 1998) . We found that RNase treatment of permeabilized nuclei releases p53, as can be seen in Figure 1d . This suggests that RNA participates, directly or indirectly, in the attachment of p53 to nuclear structures and indicates that the nuclear retention of p53 is due to nuclear matrix-binding, rather than DNA binding.
To con®rm that nuclear-bound p53 is associated with RNA, we used a combination of long-term (6 h) 5-bromouridine (BrU) labelling and co-immunoprecipitation analyses. We anticipated that the 6 h labelling time used in these experiments would label both structural and non-structural RNAs, and both would be immunoprecipitated with anti BrU antibody. BrUlabelled cells were ®rst permeabilized to remove soluble p53, including p53 associated with its own mRNA (Mosner et al., 1995) . The residual nuclear pellet was sonicated to release the bound p53 and BrU-labelled RNA was immunoprecipitated with an anti-BrU monoclonal antibody. Co-immunoprecipitating p53 was detected by immunoblotting with DO-1 ( Figure  2b , lane 2) thus con®rming that nuclear-bound p53 is associated with RNA. This is consistent with p53 binding to the nuclear matrix of which RNA is a major structural component. Western blot analysis of p53 in normal (lanes 1 and 2) and cis-Pttreated cells (lanes 3 and 4); lanes 1 and 3: nucleus-bound fraction; lanes 2 and 4: soluble fraction. (b) Immunoprecipitation of p53 after sonication of nuclear pellets from BrU-labelled cells with anti-BrU antibody (lanes 2 and 5). Lanes 1 and 4 are control for non-speci®c binding using Staphylococcus aureus A not coated with anti-BrU antibody. Lanes 3 and 6 show a p53 protein marker (sample derived from (a) lane 4). In lanes 1 ± 3 p53 is detected by Western blot with antibody DO-1; in lanes 4 ± 6, DO-1 was omitted to reveal any possible reactivity with Staphylococcus aureus A-bound rat Ig heavy chains Nuclear-bound p53 is associated with sites of low DNA density Hep G2 cells were permeabilized and washed to remove soluble p53 protein. Although paraformaldehyde-®xed cells are subsequently permeabilized in order to label internal antigens, we use the term`permeabilized cells' to indicate those that were permeabilized before ®xation. In these cells the remaining structurally bound p53 still forms a punctated pattern, as can be seen in Figure 3a . To characterize the location of nuclear-bound p53 we analysed the co-localization of p53 and PI-stained DNA. Figure 3c reveals that p53 (green) is located in regions of low DNA density (red) and is excluded from regions of densely packed heterochromatin. This is further con®rmed by correlation analysis (Figure 3d , see also Materials and methods) which shows a strong drop in correlation between p53 and DNA density at 0 shift for both the full signal and the thresholded images. This agrees with the electron microscopic observations of Katsumoto et al. (1995) . Since part of the relaxed chromatin is engaged in transcription this observation suggests that p53 may be associated with active chromatin.
p53 partially co-localizes with sites of mRNA synthesis
The cell permeabilization conditions used throughout are known to preserve nuclear architecture and the functional integrity of nuclear transcription sites (Wansink et al., 1993) . To investigate the possible association between p53 and active chromatin in more detail we performed transcription run-on experiments on permeabilized Hep G2 cells and analysed the position of p53 in relation to sites to active transcription. In our labelling conditions approximately 1800 transcription sites per nucleus were calculated (data not shown). This is in close agreement with the number of transcription sites calculated for HeLa cell nuclei (approximately 2000 sites; Pombo and Cook, 1996) , and indicates that our procedure reveals most, if not all, transcription sites. Figure 4a shows a nucleus of a Hep G2 cell double stained for p53 and transcription. As can be seen from the yellow-orange dots, there is extensive co-localization of p53 (green) and transcription sites (red). In order to (i) determine the statistical signi®cance of the colocalization, (ii) assess sizes and spatial relationships of the analysed structures and (iii) determine the percentage of co-localization, we followed the approaches of Barbarese et al. (1995) and Manders et al. (1993) . Figure 4c shows the correlation coecient vs X-axis shift plots for the original and the thresholded images ( Figure 4a and b respectively). It can be seen that for pixels above background level there is positive correlation and a gaussian can be adjusted to this pro®le suggesting that the co-localized structures are diraction-limited spots. From this gaussian shape, several spatial relationships can be analysed (Table 1 ). The correlation between red and green images peaks at zero shift (g Max =g(0) and the position of the maximum is +0.00056 mm, well below the resolution limit). A calculated correlation distance (Barbarese et al., 1995) of 0.4393 mm indicates that (i) the correlated structures have sizes comparable to the microscope resolution and (ii) positive red and green structures can be identi®ed as either co-localized or clearly separated from each other (compare with nucleolar co-localization analysis below).
The co-localization coecients, as de®ned by Manders et al. (1993) (Table 1) indicate that some but not all p53 molecules are related to transcription sites. Conversely some but not all active transcription sites show signi®cant p53 staining.
p53 is bound within the nucleolus Previous biochemical observations indicate association of p53 with nucleolar components such as the L5 ribosomal protein (Marechal et al., 1994) , topoisomerase I (Gobert et al., 1996) and the consensus DNA sequence for p53 binding in the ribosomal gene cluster DNA (Kern et al., 1991) . However, direct evidence for nucleolar localization of p53 in normal cells has not been reported. We now show that when permeabilized cells are analysed for p53 a nucleolar localization can be observed (Figure 3a ). In the absence of permeabilization nucleolar p53 is not obvious (see Figure 1a) indicating that permeabilization is necessary in order to allow access of p53 antibody reagents into nucleolar structures. Figure 4 ) and three of six nucleolar labelling (* indicates nucleoli in Figure 6a and b, repectively). g Max : maximum of the ®tted function; g (0): ®tted function at shift=0. Position of maximum and correlation distance corresponds to parameters m and s, as de®ned in Materials and methods, respectively. Percentages of co-localization were calculated as de®ned in Materials and methods, for both red (BrU-RNA) over green (p53) and green over red RNase A treatment completely abrogates detection of both nucleoplasmic and nucleolar p53 in the permeabilized cells (Figure 1d ), suggesting that RNA (rRNA?) participates in the nucleolar binding of p53.
We used ®brillarin, a protein found in the dense ®brillar component of the nucleoli, to identify nucleoli in the permeabilized cells. Dual-labelling analysis of permeabilized cells stained for p53 (red) and ®brillarin (green) allowed dierentiation of nucleoplasmic and nucleolar p53 ( Figure 5b ). As can be seen by comparison of Figure 5a (p53 only) and 5b (p53/ ®brillarin) nucleolar and nucleoplasmic levels of bound p53 are similar. By de®ning the nucleolar volume with the ®brillarin images, we were able to estimate the proportion of nucleolar p53 to be between 10 ± 20% of total nuclear bound p53. Thresholding analysis revealed that nucleolar p53 shows sharper demarcation than nucleoplasmic p53. In addition its distribution within the nucleolus is heterogeneous with some areas only weakly labelled (arrowed in Figure 5b ; see stereo pairs of Figure 5c ).
The population of Hep G2 cells contained occasional pairs in which one cell exhibited normal p53 staining whilst the adjacent cell showed little, if any, p53. When such cells were permeabilized only the p53-positive cell of the pair displayed nucleolar p53: no p53 was observed in the adjacent cell (see Figure 5 , cell marked with asterisk). This is important since it indicates that nucleolar localization of p53 is not due to sequestration of the soluble protein into the nucleolus upon permeabilization (the soluble p53 would have access to nucleoli in each of the contiguous cell pair). Similarly, when p53-null cells (Saos-2) were permeabilized in the presence of exogenous soluble p53 no uptake of p53 into the nucleolus was observed (data not shown). Further evidence against the possibility of a permeabilization artefact accounting for the nucleolar localization of p53 was evident in cells expressing mutant p53. Two types of p53 mutant were examined. The ®rst, expressed in 3T3tx cells, has abnormal p53 conformation but apparently normal oligomerization. The second mutant has wild type conformation but fails to assemble into normal quaternary structure when expressed endogenously in T3T3 cells (Milner et al., 1993) . Both p53 mutants are expressed at equivalent levels, higher than observed in normal cells, and with high levels of soluble protein (Zerrahn et al., 1992) . Nonetheless, nucleolar p53 was not evident following permeabilization and staining of either the 3T3tx or the T3T3 cells (Figure 8 ; results summarized in Table 2 ). We conclude that the nucleolar localization of wild type p53 is unlikely to be a permeabilization artefact and suggest that permeabilization is necessary in order to permit access of anti-p53 antibody into the dense nucleolar structure. A similar antibody accessibility problem has been reported for certain other nucleolar proteins (Wansink et al., 1993) and presumably re¯ects precise antigen location within the compact structure of the nucleolus.
p53 is both associated with and in close proximity to sites of rRNA synthesis
The newly observed nucleolar localization of p53 prompted us to study whether it was associated with sites of rRNA synthesis. For this purpose we carried out run-on transcription experiments in the presence of 5 mg/ml a-amanitin, thus selectively inhibiting RNA polymerase II activity (mRNA) whilst permitting continued synthesis of rRNA by polymerase I. Two discrete populations of p53 were revealed in the nucleolus. One co-localizes with newly synthesized rRNA whilst the second lies adjacent to RNA polymerase I transcription sites ( Figure 6 and Table  1 ). Attempts to ®t a gaussian to the correlation coecient vs X-axis shift plots (Figure 6 lower panel) resulted in g Max =g(0) and/or broad correlation distance (Table 1) . Furthermore, the correlation plots comprise secondary random correlation peaks at distances close to the correlation distance taking nucleoplasmic co-localization as a reference (Table 1 and Figure 6 ; examples are arrowed in the lower panel). This indicates a close packing of overlapping and non-overlapping dots, suggesting that part of nucleolar p53 is associated with rRNA transcription and part is in close proximity with rRNA transcription sites.
p53 and transcription sites co-localize in non-permeabilized intact cells Inevitably some nuclear components are lost during cell permeabilization. On transcription, this means that Figure 6 p53 is associated with rDNA transcription sites. Confocal sections of two typical Hep G2 nucleoli showing colocalization of p53 (green) and transcription sites (red) under aamanitin inhibition. Upper panels: full signal; middle panels: thresholded images; lower panels: corresponding correlation coecient vs X-axis shift plots (Ð). Arrows exemplify subsidiary peaks revealing that some p53 is close but not overlapping transcription sites. Bar is 5 mm we have no initiation (Weber et al., 1977) and that nascent transcripts cannot be processed and exported away from the transcription sites (Pombo and Cook, 1996) . To avoid these eects we microinjected BrUTP into the cytoplasm of intact cells and monitored colocalization of newly synthesized RNA with p53 in vivo. Again, the results show extensive co-localization of p53 with newly synthesized BrU-RNA in the nucleoplasm (Figure 7) . It can be seen that there is a positive correlation between the BrU-RNA and p53 signals (Figure 7c ), and this validates the observations with permeabilized nuclei (Figure 4 ). In these nonpermeabilized cells the nucleoli are practically not stained, neither for BrU-RNA nor for p53, probably due to limited antibody accessibility.
Following microinjection the percentage co-localization of p53 and BrU-RNA increased sharply within 1 min and subsequently remained relatively constant over 20 min (30 ± 40%; Figure 7d ). This is consistent with the association of p53 with sites of transcriptional elongation and con®rms our observations using permeabilized cells. P53 may also associate with transcriptional initiation but since there was no progressive co-localization of p53 with BrU-RNA (Figure 7d ) it is unlikely that p53 associates with RNA processing.
Subnuclear localization of mutant p53
In order to determine the dependence of the subnuclear localization of p53 with its phenotype we analysed two cell lines expressing two distinct types of p53 mutant. T3T3 cells express a p53 mutant that adopts a wild type conformation in vivo, but is unable to form tetramers, whereas 3T3tx cells express p53 in a mutant conformation but with apparent normal tetramerization (Milner et al., 1993) . Both cell lines express similar levels of p53 slightly higher than normal cells. In both cases a subset of p53 protein is bound within the cell nucleus (Figure 8 , see also Zerrahn et al., 1992) . Figure 8a ,b show co-localization analyses for p53 and run-on-labelled transcription sites (permeabilized cells) for typical 3T3tx and T3T3 cells respectively. Interestingly the conformational mutant of p53 in 3T3tx cells co-localizes with nucleoplasmic transcription sites as eciently as wild type p53 in a normal cell (compare Figure 8a with Figure 4 ). This indicates that the wild type conformation of p53 is not essential for association with sites of active transcription. However, p53 quaternary structure appears to be important for co-localization with sites of RNA synthesis since little, if any, co-localization was observed in the T3T3 cells (Figure 8b) . The above observations apply to nucleoplasmic p53 in the 3T3tx and T3T3 cells. Nucleolar staining in both cell lines was negligible indicating that both tertiary and quaternary structures are important for nucleolar localization of p53 (Figure 8a,b) . These results are summarized in Table 2 .
Hdm-2 is also nucleolar but does not co-localize with transcription
The known interactions between hdm-2 and p53, which can also include L5 protein and 5S RNA (Marechal et al., 1994) , prompted us to extend our analyses to hdm-2. Similarly with p53 we found that hdm-2 (i) resists cell permeabilization, and (ii) is present in the nucleoli (Figure 9a,b) . This similarity suggested that hdm-2 might also be associated with transcription sites and therefore we employed run-on transcription and double labelling for hdm-2 and BrU-RNA. Typical examples of hdm-2 and transcription localization in the nucleoplasm and the nucleoli are shown in Figure 9a ,b, respectively. It can be seen that there is no signi®cant co-localization of hdm-2 with sites of transcription and this is con®rmed by the 
Discussion
Using a combination of laser scanning microscopy and metabolic labelling we have detailed the positional status of p53 in the nucleus of non-stressed cells. In this way we sought to investigate the location of p53 within the ultrastructure of the normal cell nucleus. Such information may indicate how p53 functions to monitor genetic integrity and may also indicate additional functions of p53 in normal cells.
Nucleolar p53
Observations in vitro suggest a link between p53 and ribosomal biogenesis (Marechal et al., 1994) . The nucleolus is the major site of ribosome biogenesis and we now show for the ®rst time that p53 associates with nucleolar structures (Figure 6 ). P53 is able to bind ribosomal gene cluster DNA sequences (Kern et al., 1991) and it has recently been reported that p53 can Figure 9 Hdm-2 is not associated with active transcription sites. Confocal sections of a typical Hep G2 nucleus (left panels) and a typical nucleolus (right panels, a-amanitin inhibition) labelled for hdm-2 (green) and transcription (red). Upper panels: full signal; middle panels: thresholded images; bottom panels: corresponding correlation plots (higher plot: original image; lower plot: thresholded image). Bars: (left) 5 mm, (right) 2 mm Grummt, 1999) . However, these latter observations relate to activated p53 rather than latent p53 as studied here. Two discrete populations of latent p53 can be de®ned in the nucleolus of non-stressed cells. One co-localizes with newly synthesized rRNA whilst the second lies adjacent to RNA polymerase I transcription sites ( Figure 6 and Table 1 ; note that transcriptional run-on was in the presence of a-amanitin to inhibit RNA polymerase II activity). The sub-population of nucleolar p53 which lies adjacent to sites of rRNA transcription may be involved in ribosomal processing. This would be consistent with earlier biochemical studies indicating that cellular p53 can be covalently linked to 5.8S rRNA (Fontoura et al., 1992) . P53 has also been detected in ribonuclear protein complexes containing hdm-2, 5S rRNA and ribosomal L5 protein (Marechal et al., 1994) . Since L5 is able to localize to the nucleolus (Michael and Dreyfuss, 1996) it is possible that L5 mediates nucleolar uptake of p53 and/or hdm-2. Nucleolar hdm-2 does not localize with sites of rRNA synthesis ( Figure 9 ) and complexes containing p53 and hdm-2 may thus include those p53 molecules which lie adjacent to sites of rRNA transcription. The second nucleolar sub-population of p53 molecules co-localize with sites of active rRNA synthesis (Results section). Here the protein may interact directly with the newly synthesized rRNA. Alternatively it may associate with cellular proteins involved in rRNA synthesis such as RNA polymerase I. However no such association has, as yet, been reported. Colocalization of p53 with sites of rRNA synthesis may also relate to ribosomal biogenesis and/or serve to monitor for damage aecting actively transcribed ribosomal genes.
Nucleolar transcription is considered to occur in the transition zone between the ®brillar centres and the dense ®brillar component, whilst rRNA processing progresses from the dense ®brillar component to the granular component (Shaw and Jordan, 1995; Scheer and Hock, 1999) . High intensity ®brillarin spots reveal the dense ®brillar component. Interestingly we observed nucleolar p53 spots both in high and low ®brillarin regions thus supporting the idea that p53 might be associated with several nucleolar functions.
Association of p53 with sites of RNA synthesis
Our results reveal a sub-set of p53 molecules which are physically linked with sites of RNA synthesis in nonstressed cells (Figures 4, 6 and 7) . This was demonstrated by two alternative experimental approaches. The ®rst employed transcriptional run-on experiments in which cells are permeabilized prior to metabolic labelling with Br-UTP. Since permeabilized cells are defective for transcription initiation and RNA processing (Weber et al., 1977) we conclude that p53 colocalizes with sites of RNA transcriptional elongation under such conditions.
In addition to transcription run-on experiments we also microinjected BrUTP into living cells and monitored co-localization of p53 with newly synthesized RNA in vivo. Microinjection was cytoplasmic in order to conserve a nuclear environment where all transcription steps are performed normally. Again the results show extensive co-localization of p53 with newly synthesized RNA (Figure 7) . The percentage co-localization increased sharply within 1 min and subsequently remained relatively constant over 20 min (30 ± 40%; Figure 7d ). This indicates association of p53 with sites of transcriptional elongation and con®rms our observations using permeabilized cells. P53 may also associate with transcriptional initiation but since there was no progressive co-localization of p53 with BrU-RNA (Figure 7d ) it is unlikely that p53 associates with RNA processing.
The link between p53 activation and transcription is suggested by a variety of observations. Transcription inhibitors such as DRB and a-amanitin can activate p53 (Andera and Wasylyk, 1997; Ljungman and Zhang, 1996; Ljungman et al., 1999; te Poele et al., 1999) . Studies with UV (Ljungman and Zhang, 1996) and 5-¯uorouracil (Pritchard et al., 1997) suggest that blockage of RNA synthesis is sucient to induce a p53 response. Also, p53 can bind to components of the transcription machinery (such as TFIID, TFIIH and TBP ± see Ko and Prives, 1996) again suggesting a link between p53 and transcription. Our results thus support this view at the ultrastructural level.
Extensive evidence links transcriptional regulation with the nuclear matrix (Pederson, 1998; Stenoien et al., 1998) . Both active transcription sites and their associated transcription factors appear attached to the nuclear matrix forming a punctated pattern by optical microscopy. However, only a fraction of transcription complexes are engaged in active transcription (Grande et al., 1997; reviewed in Stenoien et al., 1998) and it has been proposed that the remaining population is in a`stand-by' position. Our observations indicate that this is also true for p53 since a proportion of p53 molecules is not related to active transcription sites (Table 1) . It is thus possible that some molecules of p53 are also associated with stand-by`silent' transcription complexes.
Monitoring of genetic integrity by p53
It has long been recognized that cells prioritize repair of DNA damage to actively transcribed genes (van Gool et al., 1997) . In fact the enhanced sensitivity with which cells with defective transcription-coupled repair (Cockayne syndrome) induce a p53 response indicates that p53 is preferentially activated by damage to actively transcribed genes (Yamaizumi and Sugano, 1994) . We now provide a cellular basis for these observations by showing that the subnuclear distribution of bound p53 in nonstressed cells is not random but localized in relaxed chromatin and associated with sites of active transcription. Thus our data suggests that the p53 protein accomplishes an ecient monitoring for genetic integrity by using the same structural framework as that used for transcription. Here we propose two novel concepts. Firstly, that the nuclear structural organization that cells employ for managing gene transcription is also used for monitoring genome integrity. Secondly, that cells manage to prioritize the repair of active chromatin regions by placing the p53 DNA damage sensor in association with active transcription sites.
Materials and methods
Cell cultures
Human Hep G2 cells (Aden et al., 1979) expressing wild type p53 (MuÈ ller et al., 1997) and murine T3T3 and 3T3tx cells expressing mutant p53 Milner et al., 1993) were cultured in DMEM with 10% FCS (Life Technologies, Paisley, UK). For immunostaining the coverslips (13 mm diameter) were coated with 0.05% poly-L-lysine (Sigma-Aldrich Co. Ltd., Dorset, UK) and were inserted in 24-well plates. The cells were then centrifuged onto them and cultured at a density of 7610 4 /well for 24 h.
Immunofluorescence
For total p53 staining cells were washed with 1 ml of PBS, ®xed for 3 min with 0.5 ml of 4% paraformaldehyde (Sigma), washed with PBS+0.05% Triton X-100 (PBS-TX) and blocked for 30 min with 1 ml of PBS-TX+10% normal goat serum (NGS). Where necessary endogenous avidin/biotin binding was blocked using a kit from Vector Laboratories (Burlingame, CA, USA). To detect nucleus-bound p53 or hdm-2, cells were permeabilized in the same conditions as for run-on transcription. Cells were washed ®rst with 1 ml of TBS buer (150 mM NaCl, 10 mM Tris, 5 mM MgCl 2 , pH 7.4), then with 1 ml of TBS-G (TBS+25% Glycerol+0.5 mM EGTA) and incubated for 3 ± 4 min in 1 ml of TBS-G-TX (TBS-G+0.05% Triton X-100). Permeabilized cells were then incubated for dierent times in 0.5 ml of the S buer (100 mM Kcl, 50 mM Tris, 10 mM MgCl 2 , 0.5 mM EGTA, 25% Glycerol). For RNase treatment 200 U/ml RNase A (Sigma) were added. After incubation cells were washed with TBS and ®xed with 4% paraformaldehyde as above. All antibody incubations were performed in 0.4 ml of PBS-TX+10% NGS for 1 h at room temperature or overnight at 48C. Washings were performed three times in PBS-TX. DO-1 and PAb242 mouse monoclonal antibodies recognizing the Nterminal region of human and mouse p53, respectively (Oncogene Research, Cambridge, MA, USA; Lane et al., 1996) , were chosen due to the absence of cross-reactivity with other cellular proteins. All the other antibodies tested (including PAb122, PAb421, 200.47, PAb1620, PAb248 and PAb240) showed cross-reactivity with cellular proteins in human and murine p53 null cells. Puri®ed DO-1 (Oncogene Research) was used at a 1 : 100 dilution; PAb242 hybridoma supernatant was used undiluted, supplemented with 10% normal goat serum; human autoimmune anti-®brillarin antibody (Sigma) was used at a 1:10 dilution; FITC-labelled rabbit anti-mouse Ig and biotinylated goat anti-mouse Ig (Dako, Glostrup, Denmark) were used at a 1 : 100 dilution; 2A9 (a mouse monoclonal antibody recognizing a region of hdm-2 that spans the NLS ± Chen et al., 1993 ± a gift from AJ Levine) tissue culture supernatant was used at a 1 : 2 dilution; FITC-labelled goat anti-human IgG was used at a 1 : 50 dilution; DTAF-streptavidin or Cy3-streptavidin (Jackson ImmunoResearch, West Grove, PA, USA) were used at a 1 : 200 dilution. After the last washing the coverslips were dipped in PBS, blotted and mounted with Vectashield (Vector Laboratories), sealing the edges with nail varnish. For DNA labelling 200 U/ml RNase A were added to ®xed cells during the ®rst antibody incubation and before mounting they were incubated in 0.1 mg/ml PI in PBS. Detection of p53 was always performed with biotin/streptavidin (either DTAF-or Cy3-conjugated). Detection of BrU-RNA, hdm-2 and ®brillarin were performed with¯uorochrome-labelled secondary antibodies.
Immunoprecipitation and Western blot
Cells (*2610 6 /plate) were grown overnight on 10 cm Petri dishes. Where indicated cells were incubated for 6 h with 0.5 mM Br-uridine (Bru) or with 10 mg/ml cis-Pt (Faulding Pharmaceuticals, Warwickshire, UK). Cells were trypsinized, washed twice with PBS and pellets were lysed with 50 ml of Lysis Buer (LB: 140 mM NaCl, 10 mM Tris, 0.5% w/v Nonidet-P40, 50 mM NaF, 1 mM Na 3 VO 4 , 5 mM EDTA, pH 8.0). For immunoprecipitation (IP) LB was supplemented with 20 mM ribonucleoside vanadyl complexes (RVC Sigma). After lysis, nuclear pellets were washed once with 200 ml of LB and recovered. For IP formalin-®xed Staphylococcus aureus A cells (Gibco) were washed in LB, incubated for 1 h with goat anti-mouse Ig (Sigma 1 ml/10 ml bacterial suspension), washed three times in LB, incubated for 1 h with a rat anti-BrdU monoclonal antibody (Harlan Sera-Lab, Belton, UK) cross-reacting with 5-bromouridine (BrU) (subsequently referred to as anti-BrU-5 ml/10 ml bacterial suspension), washed three times in LB and cross-linked for 30 min with 0.3% glutaraldehyde in PBS pH 8.0 (the extensive crossreactivity between rat and mouse immunoglobulin allowed the use of unabsorbed anti-mouse polyclonals to detect the rat antibody). The bacterial suspension was then blocked with 0.1 M glycine in PBS pH 8.0 for 30 min and then 1% BSA in LB for 30 min. Nuclear pellets for IP were resuspended in 50 ml LB and sonicated for 15 min in a water bath ensuring complete disruption of the suspension, centrifuged at 13 000 r.p.m. for 10 min and supernatants were recovered. IP was performed by adding the antibodycoated bacteria (equivalent to 20 ml of original suspension) to each sample, incubating for 1 h and washing three times in LB. Nuclear pellets (direct Western blots) or bacterial pellets (IP) were resuspended in Laemmli's sample buer and supernatants were added of an equal volume of two times Laemmli's buer and boiled for 5 min. SDS ± PAGE was performed in 15% gels. After transfer to nitrocellulose membrane, immunodetection was performed using enzyme chemiluminescence detection following the manufacturer's recommendations (Boehringer Mannheim, Lewes, Sussex, UK). Antibody dilutions for Western blots were: DO-1, 1 : 500; rabbit anti-mouse Ig-HRP (Dako) 1 : 1000 (direct Western blot); rat-Ig-absorbed goat anti-mouse Ig-HRP (Sigma) 1 : 1000 (IP). In IP-Western blot analyses controls to exclude non-speci®c binding to the immunoabsorbant and leakage of antibody heavy chain were as follows: (i) crosslinked Staphylococcus aureus A with the omission of the antiBrU antibody (Figure 2b , lanes 1 and 4) and (ii) omission of DO-1 as antibody probe in the Western blot (Figure 2b , right hand panel).
Run-on RNA synthesis and dual labelling
The protocol for run-on BrU incorporation was essentially that of Wansink et al. (1993) . Buers and incubation conditions were the same as for permeabilization with the addition of RNase inhibitors and 1 mM PMSF as follows. For the washing after synthesis, RNasin was added to 5 U/ml of TBS buer (Promega Corp., Madison, WI, USA). To TBS-G and TBS-G-TX, 10 U/ml RNasin were added. To S buer, 20 U/ml RNasin, 0.5 mM ATP, CTP, GTP (Boehringer Mannheim, Mannheim, Germany) and BrUTP (Sigma) and 25 mM S-adenosyl-L-methionine (Sigma) were added, and synthesis was performed for 30 min at 378C. For a-amanitin treatment a 5 min pre-incubation was performed in S buer without NTPs and with 5 mg/ml a-amanitin (Sigma) followed by 30 min incubation with both NTPs and a-amanitin. After synthesis cells were washed with TBS, ®xed with 0.5 ml of 4% paraformaldehyde for 3 min, washed with PBS-TX and blocked for 30 min with 0.5 ml PBS-TX+10% normal donkey serum NDS+1 mM PMSF+20 mM RVC. AntiBrU and DO-1 were used at a 1 : 100 dilution (ascites¯uid) in blocking buer and incubated in 0.4 ml overnight at 48C . Cells were washed three times in PBS-TX and ®xed again with paraformaldehyde for 3 min, washed with PBS-TX and blocked with PBS-TX+10% NDS (this eliminated the problem of RNase contamination in subsequent antibody incubations). Washings were performed three times with PBS-TX. Antibodies were incubated in 0.4 ml of PBS-TX+10% NDS for 1 h at room temperature or overnight at 48C . The subsequent incubations were: Cy3-donkey anti-rat Ig (Jackson ImmunoResearch) 1 : 100+DO-1 1 : 100 or 2A9 supernatant 1 : 2; biotinylated donkey anti-mouse Ig (Jackson ImmunoReseach) 1 : 100; DTAF-streptavidin 1 : 200. After the last washing coverslips were dipped in PBS, blotted and mounted with Vectashield, sealing the edges with nail varnish.
Microinjection
Hep G2 cells were grown on Cellocate coverslips (Eppendorf, Hamburg, Germany) and placed on a Zeiss Axiovert microscope equipped with an Eppendorf microinjector. Cells were injected into the cytoplasm with a solution containing 140 mM KCl, 2 mM PIPES pH 7.4 (Wansink et al., 1993) and 20 mM BrUTP injecting as many cells as possible during a 15 min period, followed by a further 4 min incubation at 378C. Cells were washed twice with cold PBS, ®xed (15 min) with 2% paraformaldehyde, 0.01% glutaraldehyde (EM grade, Sigma), washed twice with PBS-TX and blocked for 30 min with PBS-TX+10% NDS. After ®xation all incubations contained 10 mM RVC. Immunolabelling of p53 and BrU-RNA was performed as above.
Image acquisition and analysis
Confocal images were collected with a Carl Zeiss LSM410 confocal system using an oil immersion 663 1.4NA PlanApochromatic objective. Cells in the G 1 phase of the cell cycle were selected for analysis on the basis of nuclear size and con®rmed by independent correlation studies of DNA content with nuclear size (both quantitated by confocal microscopy ± data not shown). To maximize green uorescence detection red and green images of each Z section were collected separately by sliding a beamsplitter. Image registration was performed by using a reference sample consisting of cells labelled with DO-1 antibody and reacted with Rhodamine-and FITC-labelled secondary antibodies simultaneously. 3D cross-correlation functions between red and green images were calculated and the channel shift was determined from the position of the maxima.
Analyses of nucleoplasmic p53 and transcription were performed on 2566256 pixel images and a variable number of Z sections. For nucleolar images, 1286128 pixel subimages were used.
To eliminate noise and increase the resolution (especially for p53¯uorescence) images were deconvolved using the XCOSM software package (Biomedical Computer Laboratory, Washington University School of Medicine, St. Louis, MO, USA) running the Expectation Maximisation algorithm of Conchello et al. (1994) .
To statistically analyse the overlapping of red and green images two approaches were used. w 2 analysis over twodimensional histograms (Taneja et al., 1992 ) and Pearson's correlation coecient. w 2 analysis proved to be less sensitive than Pearson's correlation for our punctated antigen patterns, since mirrored or rotated images still displayed signi®cant correlation at high threshold values. This problem was not encountered with correlation analysis which had the additional advantage of also providing information on the size and shape of the structures analysed. Pearson's correlation coecients (r p (s)) were calculated as de®ned by Gonzalez and Woods (1993) only for a shift on the X axis: where g is a correlation index, m is the position of the centre of the correlation plot, s is a correlation distance and b is a correction factor that accounts for background contributing to the correlation. In Table 1 , g Max =r p (m)=g, and g(0)=r p (0). The shape of correlation plots reveals image features. If a large background is introduced that response will most likely resemble a triangular function, whereas isolated gaussian-like spots will produce a gaussian response.
Co-localization coecients were as de®ned by Manders et al. (1993) . At zero shift and for a given threshold T:
where the co-localization coecients M 1 and M 2 correspond to the fractions of green voxels co-localized with red voxels and red voxels co-localized with green voxels respectively; the subindex i indicates summation of voxels over the whole 3D stack; R i and G i are thresholded red and green voxels respectively (i.e. set to 0 if R i 5T or G i 5T); R i,coloc =0 if G i =0, R i,coloc =R i if G i 40, G i,coloc =0 if R i =0 and G i,coloc =G i if R i 40. Thresholds were chosen to completely eliminate background¯uorescence levels as seen in the cytoplasm, and were typically 70 ± 90 units, within the scale of 0 ± 255. Test images indicated that co-localization coecients were fairly insensitive to threshold selection with percentages diering by *5 units for threshold dierences as high as 40 units (data not shown).
To estimate the number of transcription sites we followed the approach of Fay et al. (1997) , consisting in crosscorrelating the images with a suitable point spread function (calculated according to Frisken Gibson and Lanni (1991) , as implemented in the XCOSM package) and counting the number of local maxima.
